Kuster’s Bill To Lower Cost of Prescription Drugs Passes the House
Washington, June 8, 2022
**Kuster’s legislation would lower the deficit by an estimated $546 million by cutting costs and increasing revenues, according to a report conducted by the Congressional Budget Office**
Washington, D.C. — Today, the House passed legislation authored by Rep. Annie Kuster (NH-02), the Increasing Transparency In Generic Drug Applications Act of 2022, as part of H.R. 7667, the Food and Drug Amendments of 2022 Act. Kuster’s bill would enable drug companies to bring cost-effective generic medications to the market sooner, providing lower-cost prescriptions for Granite Staters. Senator Maggie Hassan (D-NH) introduced the Senate version of this legislation last month.
“High prescription drug costs are putting pressure on far too many Granite Staters — I have heard from countless seniors and families struggling to afford the medications they need,” said Rep. Kuster. “That’s why I’m fighting every day to lower the cost of prescription drugs, and the passage of my legislation in the House is a critical step forward. My bill will help families make ends meet, especially as they face rising prices in the grocery store and at the gas pump. I look forward to the Senate sending this important legislation to the President’s Desk.”
Specifically, the Increasing Transparency In Generic Drug Applications Act of 2022 would:
The full text of this legislation is available here.